Global Embolotherapy Market 2021

January 2022 | 15 pages | ID: G362B183D85FEN
StrategyHelix Inc

Abstracts

Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. To accomplish occlusion, embolotherapy uses minimally-invasive techniques and various embolic agents, such as gelfoam, coils, balloons and angiographic catheters to achieve precise and significant results. According to StrategyHelix, the global embolotherapy market is expected to increase by US$ 1,502 million during 2021-2027, expanding at a CAGR of 6.6% during the forecast period. Growing target population, expanding applications of embolotherapy devices, escalating prevalence of chronic and lifestyle-associated diseases, increasing healthcare expenditure, and improving healthcare infrastructure are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for embolotherapy. The global embolotherapy market is segmented on the basis of product, indication, procedure, end user, and region. Based on product, the global embolotherapy market is categorized into embolic agents, support devices. Globally, the embolic agents segment made up the largest share of the embolotherapy market. On the basis of indication, the global embolotherapy market has been segmented into cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, gastrointestinal disorders. The cancer segment captured the largest share of the market in 2020. By procedure, the global embolotherapy market has been segmented into transcatheter arterial embolization, transarterial chemoembolization, transarterial radioembolization/selective internal radiation therapy. Based upon end user, the global embolotherapy market is categorized into hospitals and clinics, ambulatory surgical centers (ascs), others. Geographically, the global embolotherapy market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global embolotherapy market is highly competitive. The prominent players operating in the global embolotherapy market include Acandis GmbH, Balt Extrusion SAS, Boston Scientific Corporation, Cook Group Incorporated, Guerbet SA, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Stryker Corporation, Terumo Corporation.

Report Scope
Product: embolic agents, support devices
Indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, gastrointestinal disorders
Procedure: transcatheter arterial embolization, transarterial chemoembolization, transarterial radioembolization/selective internal radiation therapy
End user: hospitals and clinics, ambulatory surgical centers (ascs), others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global embolotherapy market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. EMBOLOTHERAPY MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

Embolic agents
Support devices

PART 4. MARKET BREAKDOWN BY INDICATION

Cancer
Neurological diseases
Peripheral vascular diseases
Urological and nephrological disorders
Gastrointestinal disorders

PART 5. MARKET BREAKDOWN BY PROCEDURE

Transcatheter arterial embolization
Transarterial chemoembolization
Transarterial radioembolization/selective internal radiation therapy

PART 6. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Ambulatory surgical centers (ascs)
Others

PART 7. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 8. KEY COMPANIES

Acandis GmbH
Balt Extrusion SAS
Boston Scientific Corporation
Cook Group Incorporated
Guerbet SA
Johnson & Johnson
Kaneka Corporation
Medtronic plc
Meril Life Sciences Private Limited
Merit Medical Systems Inc.
Penumbra, Inc.
Sirtex Medical Limited
Stryker Corporation
Terumo Corporation
About StrategyHelix
Disclaimer